Denali Therapeutics DNLI

NASDAQ DNLI

$22.30 -0.50 (-2.19%)

As of: Sep 4, 2026 · 1:32 PM EDT

Denali Therapeutics (DNLI) Notes Payables (2022)

Analysis

Denali Therapeutics (DNLI) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.27 Bn	131.42 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.55 Bn	77.56 Bn	3.93 Bn
3	Argenx Se	63.45 Bn	58.27 Bn	1.37 Bn
4	Moderna	57.73 Bn	52.59 Bn	52.00 Mn
5	Revolution Medicines	44.08 Bn	44.08 Bn	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.14 Bn	31.84 Bn	992.69 Mn
8	Royalty Pharma	28.44 Bn	27.60 Bn	-
9	Insmed	27.32 Bn	26.16 Bn	358.27 Mn
10	Denali Therapeutics	4.18 Bn	4.18 Bn	3.51 Mn

Historic Data

Historic Data

Download Data

Date	Value
Dec 31, 2022	4.39 Mn
Sep 30, 2022	1.44 Mn
Mar 31, 2022	2.71 Mn

Denali Therapeutics

NASDAQ: DNLI

$22.30 ▼ -0.50 (-2.19%)

Sep 4, 2026 · 1:32 PM EDT